A growing body of evidence suggests that the combination treatment with plant-based anticancer agents and common cancer drugs can improve effectiveness of chemotherapeutic agents through regulation of pathways, including the ones regulated by COX-2, nuclear factor-KB, and Akt (which are also associated with drug resistance) [5]. This evidence concerns the gene AKT1 and cancer.